Hostname: page-component-54dcc4c588-ff9ft Total loading time: 0 Render date: 2025-10-12T08:45:33.722Z Has data issue: false hasContentIssue false

Fucoxanthin ameliorates high-fat diet-induced kidney injury in mice

Published online by Cambridge University Press:  03 September 2025

Zhongliang Liu
Affiliation:
Department of Oncology, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, People’s Republic of China
Baogui Xu
Affiliation:
Zhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan, People’s Republic of China
Jiawen Zheng
Affiliation:
Zhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan, People’s Republic of China
Yizhou Tian
Affiliation:
Department of Oncology, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, People’s Republic of China
Zuisu Yang*
Affiliation:
Zhejiang Provincial Engineering Technology Research Center of Marine Biomedical Products, School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan, People’s Republic of China
Huiyang Shi*
Affiliation:
Department of Oncology, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, People’s Republic of China
*
Corresponding authors: Zuisu Yang; Email: abc1967@126.com; Huiyang Shi; Email: shy_188188@163.com
Corresponding authors: Zuisu Yang; Email: abc1967@126.com; Huiyang Shi; Email: shy_188188@163.com

Abstract

Consumption of a high-fat diet (HFD) is closely associated with lipid metabolism disorders and renal injury, often leading to ectopic lipid deposition, chronic inflammation, and subsequent functional impairment. Fucoxanthin (Fx), a marine-derived carotenoid, exhibits anti-inflammatory and antioxidant properties and may offer protective benefits against metabolic disturbances. This study aimed to investigate whether Fx alleviates HFD-induced kidney injury and to explore the potential mechanisms, with emphasis on oxidative stress and inflammatory pathways. Using a male C57BL/6J mouse model of H-induced nephropathy, we evaluated the effects of Fx supplementation on renal function, tissue morphology, oxidative damage markers, and inflammatory cytokine levels. Additionally, gut microbiota composition was preliminarily analyzed via 16S rDNA sequencing. The results demonstrated that Fx significantly improved renal function and reduced histological damage in the kidney. It also lowered malondialdehyde (MDA) levels and downregulated the expression of pro-inflammatory cytokines, including TNF-α, IL-6, and IL-1β. Furthermore, Fx administration improved systemic lipid profiles and metabolic health. Although shifts in gut microbial communities were observed following Fx treatment, their direct relevance to renal outcomes requires further investigation. In conclusion, fucoxanthin exerts notable renoprotective effects against HFD-induced kidney injury, largely through mitigating oxidative stress and inflammation, supporting its potential as a nutraceutical agent for preventing obesity-related renal dysfunction.

Information

Type
Research Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of the Nutrition Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

First authorship: These authors share first authorship.

References

Peng, S, Xie, Z, Zhang, X, et al. (2021) Tuina for diabetes with obesity: protocol for a systematic review and meta-analysis. Med 100, e23918.10.1097/MD.0000000000023918CrossRefGoogle ScholarPubMed
Singh, SK, Banerjee, S, Acosta, EP, et al. (2017) Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21 WAF1/CIP1 and p27 KIP1 pathway. Oncotarget 8, 1721617228.10.18632/oncotarget.15303CrossRefGoogle Scholar
Mount, PF & Juncos, LA (2017) Obesity-related CKD: when kidneys get the munchies. J Am Soc Nephrol 28, 3429.10.1681/ASN.2017080850CrossRefGoogle ScholarPubMed
Yao, YS, Li, TD & Zeng, ZH (2020) Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review. Lipids Health Dis 19, 23.10.1186/s12944-019-1171-8CrossRefGoogle ScholarPubMed
Sun, Y, Ge, X, Li, X, et al. (2020) High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction. Cell Death Dis 11, 914.10.1038/s41419-020-03122-4CrossRefGoogle ScholarPubMed
Stenvinkel, P, Chertow, GM, Devarajan, P, et al. (2021) Chronic inflammation in chronic kidney disease progression: role of Nrf2. Kidney Int Rep 6, 17751787.10.1016/j.ekir.2021.04.023CrossRefGoogle ScholarPubMed
Chen, X, Wei, W, Li, Y, et al. (2019) Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis. Chem Biol Interact 308, 269278.10.1016/j.cbi.2019.05.040CrossRefGoogle ScholarPubMed
Pongking, T, Haonon, O, Dangtakot, R, et al. (2020) A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism. PLoS One 15, e0231237.10.1371/journal.pone.0231237CrossRefGoogle ScholarPubMed
Hua, Q, Han, Y, Zhao, H, et al. (2022) Punicalagin alleviates renal injury via the gut-kidney axis in high-fat diet-induced diabetic mice. Food Funct 13, 867879.10.1039/D1FO03343CCrossRefGoogle ScholarPubMed
Terasaki, M, Kubota, A, Kojima, H, et al. (2021) Fucoxanthin and colorectal cancer prevention. Cancers (Basel) 13, 2379.10.3390/cancers13102379CrossRefGoogle ScholarPubMed
Wu, SJ, Liou, CJ, Chen, YL, et al. (2021) Fucoxanthin ameliorates oxidative stress and airway inflammation in tracheal epithelial cells and asthmatic mice. Cells 10, 1311.10.3390/cells10061311CrossRefGoogle ScholarPubMed
Maeda, H, Hosokawa, M, Sashima, T, et al. (2009) Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol Med Rep 2, 897902.CrossRefGoogle ScholarPubMed
Mao, H, Wang, L, Xiong, Y, et al. (2022) Fucoxanthin attenuates oxidative damage by activating the Sirt1/Nrf2/HO-1 signaling pathway to protect the kidney from ischemia-reperfusion injury. Oxid Med Cell Longev 2022, 7444430.10.1155/2022/7444430CrossRefGoogle ScholarPubMed
Yang, H, Xing, R, Liu, S, et al. (2021) Role of fucoxanthin towards cadmium-induced renal impairment with the antioxidant. Bioengineered 12, 72357247.10.1080/21655979.2021.1973875CrossRefGoogle ScholarPubMed
Chen, Y, Li, R, Hu, N, et al. (2020) Baihe Wuyao decoction ameliorates CCl4;-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects. J Ethnopharmacol 263, 113227.10.1016/j.jep.2020.113227CrossRefGoogle Scholar
Sterling, SR & Bowen, SA (2019) The potential for plant-based diets to promote health among blacks living in the United States. Nutrients 11, 2915.10.3390/nu11122915CrossRefGoogle ScholarPubMed
Ananthakrishnan, S & Kaysen, GA (2016) Treatment of hyperlipidemia changes with level of kidney function-rationale. Adv Chronic Kidney Dis 23, 247254.10.1053/j.ackd.2015.12.004CrossRefGoogle ScholarPubMed
Yang, G, Li, Q, Peng, J, et al. (2021) Fucoxanthin regulates Nrf2 signaling to decrease oxidative stress and improves renal fibrosis depending on Sirt1 in HG-induced GMCs and STZ-induced diabetic rats. Eur J Pharmacol 913, 174629.10.1016/j.ejphar.2021.174629CrossRefGoogle ScholarPubMed
Li, L, Chen, Y, Jiao, D, et al. (2020) Protective effect of astaxanthin on ochratoxin A-induced kidney injury to mice by regulating oxidative stress-related NRF2/KEAP1 pathway. Mol 25, 1386.10.3390/molecules25061386CrossRefGoogle ScholarPubMed
Yang, S, Li, J, Yan, L, et al. (2024) Molecular mechanisms of fucoxanthin in alleviating lipid deposition in metabolic associated fatty liver disease. J Agric Food Chem 72, 1039110405.10.1021/acs.jafc.4c00590CrossRefGoogle ScholarPubMed
Luo, Y, Chen, H, Liu, H, et al. (2020) Protective effects of ferroptosis inhibition on high fat diet-induced liver and renal injury in mice. Int J Clin Exp Pathol 13, 20412049.Google ScholarPubMed
Wang, W, Liu, H, Zhang, Y, et al. (2019) Antihyperlipidemic and hepatoprotective properties of alkali- and enzyme-extractable polysaccharides by Dictyophora indusiata . Sci Rep 9, 14266.CrossRefGoogle ScholarPubMed
Song, X, Liu, Z, Zhang, J, et al. (2018) Antioxidative and hepatoprotective effects of enzymatic and acidic-hydrolysis of Pleurotus geesteranus mycelium polysaccharides on alcoholic liver diseases. Carbohydr Polym 201, 7586.CrossRefGoogle ScholarPubMed
Yamamoto, T, Takabatake, Y, Takahashi, A, et al. (2017) High-fat diet-induced lysosomal dysfunction and impaired autophagic flux contribute to lipotoxicity in the kidney. J Am Soc Nephrol 28, 15341551.10.1681/ASN.2016070731CrossRefGoogle ScholarPubMed
Zhang, Q, Tao, X, Xia, S, et al. (2019) Emodin attenuated severe acute pancreatitis via the P2X ligand-gated ion channel 7/NOD-like receptor protein 3 signaling pathway. Oncol Rep 41, 270278.Google ScholarPubMed
Komada, T & Muruve, DA (2019) The role of inflammasomes in kidney disease. Nat Rev Nephrol 15, 501520.10.1038/s41581-019-0158-zCrossRefGoogle ScholarPubMed
Rajamaki, K, Mayranpaa, MI, Risco, A, et al. (2016) p38delta MAPK: a novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis. Arterioscler Thromb Vasc Biol 36, 19371946.10.1161/ATVBAHA.115.307312CrossRefGoogle ScholarPubMed
Ma, L, Xu, H, Zhu, J, et al. (2011) Ras1(CA) overexpression in the posterior silk gland improves silk yield. Cell Res 21, 934943.10.1038/cr.2011.36CrossRefGoogle ScholarPubMed
Wang, Y, Zhang, W, Yu, G, et al. (2018) Cytoprotective effect of aquaporin 1 against lipopolysaccharide-induced apoptosis and inflammation of renal epithelial HK-2 cells. Exp Ther Med 15, 42434252.Google ScholarPubMed
Hedl, M & Abraham, C (2012) Nod2-induced autocrine interleukin-1 alters signaling by ERK and p38 to differentially regulate secretion of inflammatory cytokines. Gastroenterology 143, 15301543.CrossRefGoogle ScholarPubMed
Foley, KP, Zlitni, S, Denou, E, et al. (2018) Long term but not short term exposure to obesity related microbiota promotes host insulin resistance. Nat Commun 9, 4681.10.1038/s41467-018-07146-5CrossRefGoogle Scholar
Supplementary material: File

Liu et al. supplementary material

Liu et al. supplementary material
Download Liu et al. supplementary material(File)
File 34.6 KB